Skip to content

CEDEK MEDICAL: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CEDEK MEDICAL

BE 0443.485.087
NACE 32.500, Manufacture of medical and dental instruments and supplies
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€276,198
2024 · €335,634-€59,436
Equity
€941,228
2024 · €665,030+€276,198
Cash
€287,192
2024 · €483,639-€196,447
Balance sheet total
€1.2m
2024 · €1.1m+€56,197

Largest movements

2024 to 2025
Assets
  • Cash -€196,447

    down €196,447 (-40.6%), from €483,639 to €287,192

    mainly Trade debts (-€232,998) and Receivables within one year (-€174,676)

  • Receivables within one year +€174,676

    up €174,676 (+36.4%), from €480,424 to €655,100

    of which Other amounts receivable: +€160,995

  • Tangible fixed assets +€66,851

    up €66,851 (+117%), from €57,259 to €124,110

    of which Furniture and vehicles: +€73,457

  • Stocks and contracts +€12,140

    up €12,140 (+10.0%), from €120,903 to €133,043

Equity and liabilities
  • Profit (loss) carried forward +€276,198

    up €276,198 (+82.3%), from €335,634 to €611,831

  • Trade debts -€232,998

    down €232,998 (-57.7%), from €403,547 to €170,549

  • Tax, wage and social debts +€54,890

    up €54,890 (+207%), from €26,555 to €81,446

    of which Taxes: +€41,439

  • Current portion of long-term debt -€41,250

    down €41,250 (-100%), from €41,250 to €0

Income statement
  • Gross operating margin -€54,563

    down €54,563 (-7.8%), from €698,875 to €644,313

  • Depreciation +€14,754

    up €14,754 (+98.0%), from €15,048 to €29,802

  • Taxes -€12,986

    down €12,986 (-11.3%), from €115,254 to €102,268

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €335,634
Gross operating margin -€54,563
Staff costs -€6,609
Depreciation -€14,754
Other operating charges -€3,069
Financial income +€5,187
Financial charges +€1,385
Taxes +€12,986
Result 2025 €276,198
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€60,144
Investment -€95,053
Financing -€41,250
Cash 2024 €483,639
Net result for the year +€276,198
Depreciation +€29,802
Stocks and contracts -€12,140
Receivables within one year -€174,676
Smaller working-capital items -€1,219
Trade debts -€232,998
Tax, wage and social debts +€54,890
Investment in fixed assets (net) -€95,053
Current portion of long-term debt -€41,250
Cash 2025 €287,192
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,148,405 €1,204,602 +€56,197 +4.9%
Fixed assets 21/28 €62,750 €128,001 +€65,251 +104%
Intangible fixed assets 21 €4,660 €3,060 -€1,600 -34.3%
Tangible fixed assets 22/27 €57,259 €124,110 +€66,851 +117%
Plant, machinery and equipment 23 €3,129 €967 -€2,162 -69.1%
Furniture and vehicles 24 €37,343 €110,800 +€73,457 +197%
Other tangible fixed assets 26 €16,788 €12,344 -€4,444 -26.5%
Financial fixed assets 28 €831 €831 = 0.0%
Current assets 29/58 €1,085,655 €1,076,601 -€9,054 -0.8%
Stocks and contracts in progress 3 €120,903 €133,043 +€12,140 +10.0%
Stocks 30/36 €120,903 €133,043 +€12,140 +10.0%
Amounts receivable within one year 40/41 €480,424 €655,100 +€174,676 +36.4%
Trade receivables 40 €450,019 €463,700 +€13,681 +3.0%
Other amounts receivable 41 €30,405 €191,401 +€160,995 +529%
Cash at bank and in hand 54/58 €483,639 €287,192 -€196,447 -40.6%
Deferred charges and accrued income 490/1 €689 €1,265 +€576 +83.7%
Total equity and liabilities 10/49 €1,148,405 €1,204,602 +€56,197 +4.9%
Equity 10/15 €665,030 €941,228 +€276,198 +41.5%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €310,805 €310,805 = 0.0%
Distributable reserves 133 €310,805 €310,805 = 0.0%
Profit (loss) carried forward 14 €335,634 €611,831 +€276,198 +82.3%
Amounts payable 17/49 €483,374 €263,374 -€220,001 -45.5%
Amounts payable within one year 42/48 €483,374 €263,374 -€220,001 -45.5%
Current portion of amounts payable after more than one year 42 €41,250 €0 -€41,250 -100%
Trade debts 44 €403,547 €170,549 -€232,998 -57.7%
Suppliers 440/4 €403,547 €170,549 -€232,998 -57.7%
Taxes, remuneration and social security 45 €26,555 €81,446 +€54,890 +207%
Taxes 450/3 €274 €41,713 +€41,439 +15,105%
Remuneration and social security 454/9 €26,281 €39,732 +€13,451 +51.2%
Other amounts payable 47/48 €12,022 €11,379 -€643 -5.3%
Accrued charges and deferred income 492/3 €0 - =
Remuneration, social security and pensions 62 €236,810 €243,418 +€6,609 +2.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €15,048 €29,802 +€14,754 +98.0%
Other operating charges 640/8 €1,182 €4,250 +€3,069 +260%
Gross operating margin 9900 €698,875 €644,313 -€54,563 -7.8%
Operating profit (loss) 9901 €445,835 €366,842 -€78,993 -17.7%
Financial income 75/76B €9,236 €14,422 +€5,187 +56.2%
Recurring financial income 75 €9,236 €14,422 +€5,187 +56.2%
Financial charges 65/66B €4,184 €2,799 -€1,385 -33.1%
Recurring financial charges 65 €4,184 €2,799 -€1,385 -33.1%
Profit (loss) for the period before taxes 9903 €450,888 €378,466 -€72,422 -16.1%
Income taxes 67/77 €115,254 €102,268 -€12,986 -11.3%
Profit (loss) for the period 9904 €335,634 €276,198 -€59,436 -17.7%
Profit (loss) for the period to be appropriated 9905 €335,634 €276,198 -€59,436 -17.7%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.